Cite
MLA Citation
Marla Weetall et al.. “Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress‐Regulated Protein Translation.” Clinical pharmacology in drug development, vol. 5, no. 4, n.d., pp. 296–305. http://access.bl.uk/ark:/81055/vdc_100033036982.0x000018